This has been demonstrated using isogenic pairs of human breast epithelial cells (HMLE), which, unlike differentiated tumor cells, where Nrf2 activation is typically a response to oxidative stress via the PERK-mediated UPR pathway, exhibit constitutive PERK-Nrf2 signaling. Here, NFE2L2 is linked to neoplasm.